Uveal Melanoma: Survival Prognostic Factors

  • Shahar Frenkel*
  • , Jacob Pe’er
  • , Robert Folberg
  • *Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Uveal melanomas are among the few cancers that are diagnosed clinically without a tissue diagnosis before treatment. The primary tumor poses few therapeutic challenges, but when metastases become apparent clinically, we still have little to offer patients. The prognosis was previously based only on clinical features. However, in recent decades, there has been tremendous progress in the understanding of tumorigenesis and tumor biology from the data obtained by a variety of sampling methods. This knowledge of chromosomal abnormalities, primary and secondary driver mutations, and tumor factors in the aqueous fluid and the general circulation are all used to predict which patients will develop metastases and when. In this chapter, we review recent advances in uveal melanoma prognostication. Moreover, it seems that not all metastases behave in the same fashion. Thus, we also touch on the prognostication of the metastatic disease itself.

Original languageEnglish
Title of host publicationClinical Ophthalmic Oncology
Subtitle of host publicationUveal Tumors
PublisherSpringer Science+Business Media
Pages267-278
Number of pages12
ISBN (Electronic)9783031813542
ISBN (Print)9783031813535
DOIs
StatePublished - 1 Jan 2025

Bibliographical note

Publisher Copyright:
© 2025 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG.

Keywords

  • Anatomic predictors
  • Genetic predictors
  • Histological predictors
  • Liquid biopsy
  • Melanoma prognostication
  • Prognostic factors

Fingerprint

Dive into the research topics of 'Uveal Melanoma: Survival Prognostic Factors'. Together they form a unique fingerprint.

Cite this